Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,189 | 1,210 | 8,308 | 2,115 | 1,727 |
| Operating Income | -1,189 | -1,210 | -8,308 | -2,115 | -1,727 |
| Interest Expense | 149 | 95 | 58 | 96 | 103 |
| Other Income | -11 | -23 | 47 | 13 | -3 |
| Pre-tax Income | -1,348 | -1,328 | -8,320 | -2,197 | -1,834 |
| Net Income Continuous | -1,348 | -1,328 | -8,320 | -2,197 | -1,729 |
| Net Income | $-1,348 | $-1,328 | $-8,320 | $-2,197 | $-1,729 |
| EPS Basic Total Ops | -0.03 | -0.03 | -0.19 | -0.05 | -0.04 |
| EPS Basic Continuous Ops | -0.03 | -0.03 | -0.19 | -0.05 | -0.04 |
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.19 | -0.05 | -0.04 |
| EPS Diluted Continuous Ops | -0.03 | -0.03 | -0.19 | -0.05 | -0.04 |
| EBITDA(a) | $-1,151 | $-1,210 | $-8,255 | $-2,088 | $-1,729 |